These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35285356)

  • 21. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
    Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
    Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunotherapy in pediatrics.
    Arasi S; Castagnoli R; Pajno GB
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():51-53. PubMed ID: 32017209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Future of Food Allergy Management: Advancements in Therapies.
    Ezhuthachan ID; Beaudoin M; Nowak-Wegrzyn A; Vickery BP
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):161-171. PubMed ID: 38393624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral desensitization in IgE-mediated food allergy: Effectiveness and safety.
    Calvani M; Bianchi A; Imondi C; Romeo E
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():49-50. PubMed ID: 32017216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
    Parrish CP; Har D; Andrew Bird J
    Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Immunotherapy: An Overview.
    Todoric K; Merrill S
    Med Clin North Am; 2024 Jul; 108(4):719-731. PubMed ID: 38816113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cow's Milk Desensitization in Anaphylactic Patients: A New Personalized-dose Method.
    Babaie D; Nabavi M; Arshi S; Mesdaghi M; Chavoshzadeh Z; Bemanian MH; Tafakori M; Amirmoini M; Esmailzadeh H; Molatefi R; Rekabi M; Akbarpour N; Masoumi F; Fallahpour M
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):45-52. PubMed ID: 28417624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.
    Yee CS; Rachid R
    Curr Allergy Asthma Rep; 2016 Apr; 16(4):25. PubMed ID: 26922433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting IgE to facilitate oral immunotherapy for food allergy: a potential new role for anti-IgE therapy?
    Umetsu DT
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1125-8. PubMed ID: 25119422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety profile of oral immunotherapy with cow's milk and hen egg: A 10-year experience in controlled trials.
    Pajno GB; Caminiti L; Chiera F; Crisafulli G; Salzano G; Arasi S; Passalacqua G
    Allergy Asthma Proc; 2016 Sep; 37(5):400-3. PubMed ID: 27657524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient quality of life following induction of oral immunotherapy for food allergy.
    Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
    Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral.
    Koren Y; Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Elizur A
    Pediatr Res; 2023 Feb; 93(3):643-648. PubMed ID: 35641552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peanut Oral Immunotherapy: State of the Art.
    Tang MLK; Lozinsky AC; Loke P
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):97-110. PubMed ID: 31761124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of Multifood Oral Immunotherapy in Children Aged 1 to 18 Years at an Academic Pediatric Clinic.
    Nguyen K; Lewis MO; Hanna E; Alfaro MKC; Corrigan K; Buonanno J; Datta R; Brown-Whitehorn T; Spergel JM; Cianferoni A
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1907-1913.e1. PubMed ID: 36907355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral and sublingual immunotherapy for food allergy.
    Nowak-Wegrzyn A; Sato S; Fiocchi A; Ebisawa M
    Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):606-613. PubMed ID: 31524655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
    Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.
    Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
    Allergy; 2020 Oct; 75(10):2623-2632. PubMed ID: 32350869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.